Sibutramine

Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons, yet it still keeps finding its way into the hands of innocent people.

According to the FDA " sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. These products may also interact, in life-threatening ways, with other medications a consumer may be taking."

Thankfully, the FDA has been able to alert consumers of this substance, sibutramine, and the weight loss companies that sell sibutramine laced products.



Meizi Super Power Fruits Herbal Slimming Formula contains sibutramine; as confirmed by FDA labs and reported to consumers on September 3, 2015.

They are advising consumers not to purchase or use Meizi Super Power Fruits Herbal Slimming Formula, a product promoted and sold for weight loss on the website, www.slimeast.com.

As always:
"Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program:
Complete and submit the report online MedWatch Online Voluntary Reporting Form, or:
Download and complete the form, then submit it via fax at 1-800-FDA-0178."

source:

SmartLipo365

SmartLipo365 Issues Voluntary Nationwide Recall of Smart Lipo Due to 

Undeclared Sibutramine, Desmethylsibutramine, and Phenolphthalein

FOR IMMEDIATE RELEASE — June 3, 2015 — Dallas, TX,

SmartLipo365 is voluntarily recalling 122 lots of Smart Lipo (800, 900, 950 mg) capsules, to the consumer level. FDA received samples of 800 and 900mg capsules of Smart Lipo and the lab results found the Smart Lipo products to contain undeclared sibutramine, desmethylsibutramine, and phenolphthalein.

Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

Phenolphthalein is an ingredient previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is not currently approved for marketing in the United States. Health risks associated with phenolphthalein could include potentially serious gastrointestinal disturbances, irregular heartbeat, and cancer with long-term use.

These undeclared ingredients make these products unapproved new drugs for which safety and efficacy have not been established.
These products may also interact in life-threatening ways with other medications a consumer may be taking.

Overseas Product: Botanical Slimming (Red) contains hidden drug ingredient

Medication Health Fraud Public Notification: Botanical Slimming (Red) contains hidden drug ingredient


Fluoxetine is used for treating depression, bulimia, obsessive-compulsive disorder (OCD), panic disorder, and premenstrual dysphoric disorder (PMDD).


It was found in this product!

Serious side effects including

• suicidal thinking,
• abnormal bleeding
• seizures. 

In patients on other medications for common conditions (aspirin, ibuprofen, or other drugs for depression, anxiety, bipolar illness, blood clots, chemotherapy, heart conditions, and psychosis), ventricular arrhythmia or sudden death can occur.

view full article here:

Recalls, Market Withdrawals, & Safety Alerts Ultra ZX LABS, L.L.C. Issues Voluntary Nationwide Recall of Ultra ZX Since It Contains Undeclared Sibutramine and Phenolphthalein

Recalls, Market Withdrawals, & Safety Alerts Ultra ZX LABS, L.L.C. Issues Voluntary Nationwide Recall of Ultra ZX Since It Contains Undeclared Sibutramine and Phenolphthalein